adenosine has been researched along with Inflammatory Response Syndrome, Systemic in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Börner, MS; Castro, JJ; López, F; Pellegrini, A; Salzberg, S | 1 |
| Brusini, R; Cailleau, C; Couvreur, P; Dormont, F; Gaudin, F; Gendron, A; Mougin, J; Peramo, A; Reynaud, F; Varna, M | 1 |
| Bellezza, M; Blayac, D; Bruzzese, L; Fromonot, J; Garibaldi, V; Giorgi, R; Guieu, R; Kerbaul, F; Kipson, N; Lejeune, PJ; Nee, L | 1 |
| Buser, PT; Haschke, M; Krisai, P; Mueller, C | 1 |
| Bénard, F; Bénas, V; Blayac, D; Carrega, L; Collart, F; Gariboldi, V; Gérolami, V; Giorgi, R; Guieu, R; Kerbaul, F; Mercier, L; Youlet, B; Zouher, I | 1 |
| Kox, M; Masereeuw, R; Mbuyi, F; Pickkers, P; Ramakers, BP; Riksen, NP; Rongen, G; Smits, P; van den Broek, PH; van der Hoeven, JG; Wever, KE | 1 |
| Dale, N; Gourine, AV; Gourine, VN; Spyer, KM | 1 |
| Conlon, BA; Law, WR; Ross, JD | 1 |
| Collart, F; Gil, JM; Giorgi, R; Gouin, F; Guieu, R; Guillen, JC; Habib, G; Ibrahim, Z; Kerbaul, F; Mouly-Bandini, A; Saadjian, A | 1 |
2 review(s) available for adenosine and Inflammatory Response Syndrome, Systemic
| Article | Year |
|---|---|
Fever in systemic inflammation: roles of purines.
Topics: Adenosine; Adenosine Triphosphate; Animals; Fever; Humans; Systemic Inflammatory Response Syndrome | 2004 |
Advances in understanding adenosine as a plurisystem modulator in sepsis and the systemic inflammatory response syndrome (SIRS).
Topics: Adenosine; Animals; Cytokines; Humans; Immune System; Purinergic P1 Receptor Agonists; Purinergic P1 Receptor Antagonists; Sepsis; Systemic Inflammatory Response Syndrome | 2005 |
7 other study(ies) available for adenosine and Inflammatory Response Syndrome, Systemic
| Article | Year |
|---|---|
[Systemic inflammatory response syndrome associated with use of ticagrelor].
Topics: Acute Coronary Syndrome; Adenosine; Humans; Myocardial Infarction; Systemic Inflammatory Response Syndrome; Ticagrelor | 2021 |
Squalene-based multidrug nanoparticles for improved mitigation of uncontrolled inflammation in rodents.
Topics: Adenosine; alpha-Tocopherol; Animals; Antioxidants; Betacoronavirus; Coronavirus Infections; COVID-19; Disease Models, Animal; Drug Delivery Systems; Endotoxemia; Female; Immunologic Factors; Lipopolysaccharides; Male; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Nanoparticles; Pandemics; Pneumonia, Viral; SARS-CoV-2; Squalene; Systemic Inflammatory Response Syndrome; Treatment Outcome | 2020 |
Ischemia-modified albumin and adenosine plasma concentrations are associated with severe systemic inflammatory response syndrome after cardiopulmonary bypass.
Topics: Adenosine; Aged; Albumins; Anesthesia; Biomarkers; Cardiopulmonary Bypass; Coronary Disease; Female; Hemodynamics; Humans; Male; Middle Aged; Prospective Studies; Systemic Inflammatory Response Syndrome | 2013 |
Ticagrelor induced systemic inflammatory response syndrome.
Topics: Acute Coronary Syndrome; Adenosine; Administration, Oral; Aged, 80 and over; Follow-Up Studies; Humans; Male; Purinergic P2Y Receptor Antagonists; Systemic Inflammatory Response Syndrome; Ticagrelor | 2017 |
Adenosine A2A receptor hyperexpression in patients with severe SIRS after cardiopulmonary bypass.
Topics: Adenosine; Adult; Aged; Cardiopulmonary Bypass; Case-Control Studies; Female; Gene Expression; Humans; Male; Middle Aged; Prospective Studies; Receptors, Adenosine A2; RNA, Messenger; Systemic Inflammatory Response Syndrome | 2008 |
How systemic inflammation modulates adenosine metabolism and adenosine receptor expression in humans in vivo.
Topics: Adenosine; Analysis of Variance; Cells, Cultured; Cytokines; Down-Regulation; Endotoxemia; Endotoxins; Gene Expression Regulation; Human Experimentation; Humans; Leukocytes, Mononuclear; Lipopolysaccharides; Lymphocytes; Male; Real-Time Polymerase Chain Reaction; Receptors, Purinergic P1; Reference Values; RNA, Messenger; Sampling Studies; Systemic Inflammatory Response Syndrome; Young Adult | 2012 |
Role of endogenous adenosine as a predictive marker of vasoplegia during cardiopulmonary bypass and postoperative severe systemic inflammatory response.
Topics: Adenosine; Aged; Biomarkers; Cardiopulmonary Bypass; Female; Hemodynamics; Humans; Male; Prospective Studies; Statistics, Nonparametric; Systemic Inflammatory Response Syndrome; Vascular Diseases; Vascular Resistance; Vasodilation; Vasodilator Agents | 2006 |